Newbury Pharmaceuticals (Sweden) Probability of Future Stock Price Finishing Over 14.25
| NEWBRY Stock | 3.62 0.08 2.26% |
Newbury |
Newbury Pharmaceuticals Target Price Odds to finish over 14.25
The tendency of Newbury Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 14.25 or more in 90 days |
| 3.62 | 90 days | 14.25 | close to zero percent |
Based on a normal probability distribution, the odds of Newbury Pharmaceuticals to move over 14.25 or more in 90 days from now is close to zero percent (This Newbury Pharmaceuticals AB probability density function shows the probability of Newbury Stock to fall within a particular range of prices over 90 days) . Probability of Newbury Pharmaceuticals price to stay between its current price of 3.62 and 14.25 at the end of the 90-day period is about 50.0 .
Assuming the 90 days trading horizon Newbury Pharmaceuticals has a beta of 0.0949. This indicates as returns on the market go up, Newbury Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Newbury Pharmaceuticals AB will be expected to be much smaller as well. Additionally Newbury Pharmaceuticals AB has an alpha of 0.2757, implying that it can generate a 0.28 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Newbury Pharmaceuticals Price Density |
| Price |
Predictive Modules for Newbury Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Newbury Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Newbury Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Newbury Pharmaceuticals is not an exception. The market had few large corrections towards the Newbury Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Newbury Pharmaceuticals AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Newbury Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.28 | |
β | Beta against Dow Jones | 0.09 | |
σ | Overall volatility | 0.32 | |
Ir | Information ratio | 0.05 |
Newbury Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Newbury Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Newbury Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Newbury Pharmaceuticals had very high historical volatility over the last 90 days | |
| Newbury Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| About 79.0% of the company outstanding shares are owned by corporate insiders |
Newbury Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Newbury Stock often depends not only on the future outlook of the current and potential Newbury Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Newbury Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 19.5 M |
Newbury Pharmaceuticals Technical Analysis
Newbury Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Newbury Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Newbury Pharmaceuticals AB. In general, you should focus on analyzing Newbury Stock price patterns and their correlations with different microeconomic environments and drivers.
Newbury Pharmaceuticals Predictive Forecast Models
Newbury Pharmaceuticals' time-series forecasting models is one of many Newbury Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Newbury Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Newbury Pharmaceuticals
Checking the ongoing alerts about Newbury Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Newbury Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Newbury Pharmaceuticals had very high historical volatility over the last 90 days | |
| Newbury Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| About 79.0% of the company outstanding shares are owned by corporate insiders |
Other Information on Investing in Newbury Stock
Newbury Pharmaceuticals financial ratios help investors to determine whether Newbury Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Newbury with respect to the benefits of owning Newbury Pharmaceuticals security.